Memorial Sloan Kettering Cancer Center

Every year, researchers at Memorial Sloan Kettering Cancer Center (MSK) work to advance the global understanding of cancer and develop new therapies, and 2024 was no exception. “MSK scientists continue to expand our understanding of cancer and to apply what we learn in the lab to improve the lives of patients," says MSK President and CEO Dr. Selwyn Vickers. "The discoveries that we’re making today provide the foundation for the therapies of tomorrow.” Learn about some of the most exciting scientific discoveries reported over the past year, in chronological order: https://lnkd.in/e_Q8JhuG

"Cancer patients’ lives are on the line. Anthem can demonstrate its commitment to its patients by agreeing to a fair and sustainable contract with MSK." Memorial Sloan Kettering’s work to end cancer for life is vital for many, but we cannot continue to deliver exceptional patient care without partnership with insurance companies. Read more from MSK's Chief Financial Officer Mike Harrington: https://bit.ly/4gK4nKw

🎙️MUST LISTEN: In this special holiday episode of Cancer Straight Talk, patients, caregivers and clinicians at Memorial Sloan Kettering Cancer Center (MSK) share the ✨miracles✨ they’ve witnessed, even in the darkest of times. From life-saving medicine to gratitude for caregivers and a surprise romance, these stories remind us of the power of human connection. (Grab the tissues for some happy tears!) Listen to the full episode here: https://bit.ly/4ft0BE0

New research from Memorial Sloan Kettering Cancer Center (MSK) uncovers clues about how cells control a key DNA repair protein; develops a new method for studying gene amplifications in cancer; sheds new light on tumor suppressor genes; shows MSK-IMPACT® could be used for HLA genotype screening to predict response to cellular therapies; and more: https://bit.ly/3ByFp1I

It takes a village (and nearly six weeks!) to create the festive magic of the Holiday Hallway at Memorial Sloan Kettering Cancer Center (MSK). Members of eight shop departments at MSK made the hallway shine this year with more than 22,000 lights, more than 300 houses and structures, and 22 elves on a shelf. They also erected six large toy soldiers and a five-foot-tall carousel and assembled 250 linear feet of train track. “Each light and ornament is a reminder to the brave children, their families, and everyone that comes through the space that even in the toughest battles, moments of magic and warmth are possible," says Edward Bujnak, Associate Director of Facilities Management at MSK. Watch the entire process here.

Thanks to the life-changing results from a clinical trials led by Dr. Andrea Cercek, a gastrointestinal oncologist at Memorial Sloan Kettering Cancer Center (MSK), Jessica (a patient living in San Diego) is now cancer-free after being diagnosed with stage 3 rectal cancer. Jessica's oncologist in San Diego was able to treat her with the same immunotherapy-only approach from Dr. Cercek's clinical trial, which is now an FDA Designated Breakthrough therapy. Watch as Jessica was able to express her heartfelt gratitude for Dr. Cercek over Zoom. Learn more about Dr. Cercek's trial: https://lnkd.in/em5p8-dZ

This year's Memorial Sloan Kettering Cancer Center (MSK) Health Equity Conference brought together experts from various fields, institutions, and specialties to speak about ways we can improve health equity for communities that are underserved due to limited access to healthcare. Through diversity of perspectives and expertise, the conference helped highlight the many different ways one can improve health equity in their own practice and institution. Swipe through to view a few images from the event.

Happening now: Join breast oncologist Dr. Pedram Razavi as he presents new research from his team, including lead author and computational biologist Enrico Moiso, on metastatic breastcancer at the San Antonio Breast Cancer Symposium. #SABCS24

Highlights from the American Society of Hematology Annual Meeting include practice-changing insights for patients with multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia. Learn more about research from MSK experts, including Dr. Urvi Shah, Dr. Megan Thompson, Dr. Leora Boussi, and more: https://bit.ly/49EbS35

#SABCS24: Join postdoctoral researcher Dr. Avantika Gupta for her presentation on "APOBEC3 mutagenesis induces resistance-promoting genomic alterations in breast cancer" today at 11:30am CT at the San Antonio Breast Cancer Symposium.